Andrew Witty: the acceptable face of big pharma?

    loading  Checking for direct PDF access through Ovid

Abstract

Following GlaxoSmithKline's announcement that it will open up its research data, Rebecca Coombes spoke to the company's chief executive, Andrew Witty, about how he is trying to change the company

Related Topics

    loading  Loading Related Articles